SpineEx files for $17M IPO: 3 notes

Shayna Korol -   Print  |

SpineEx filed to raise up to $17 million in an initial public offering Sept. 18, Renaissance Capital reports.

Here are three things to know:

1. SpineEx develops implants for spinal fusion surgery.

2. ThinkEquity is the deal's only bookrunner.

3. Pricing terms were not disclosed.

More articles on devices:
Medtronic, Zimmer Biomet, Smith & Nephew & more: 15 device company notes
18 spine devices received FDA 510(k) clearance in August
Medtronic joins initiative to bring more women into board seats

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers